These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32130727)

  • 1. Inoculum size and traits of the infecting clinical strain define the protection level against Mycobacterium tuberculosis infection in a rabbit model.
    Tsenova L; Fallows D; Kolloli A; Singh P; O'Brien P; Kushner N; Kaplan G; Subbian S
    Eur J Immunol; 2020 Jun; 50(6):858-872. PubMed ID: 32130727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
    PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the Effect of Vaccination on Host-Pathogen Interactions in a Murine Model of Pulmonary Tuberculosis by
    Zatarain-Barrón ZL; Ramos-Espinosa O; Marquina-Castillo B; Barrios-Payán J; Cornejo-Granados F; Maya-Lucas O; López-Leal G; Molina-Romero C; Anthony RM; Ochoa-Leyva A; De La Rosa-Velázquez IA; Rebollar-Vega RG; Warren RM; Mata-Espinosa DA; Hernández-Pando R; van Soolingen D
    Front Immunol; 2020; 11():930. PubMed ID: 32508826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCG sub-strains induce variable protection against virulent pulmonary Mycobacterium tuberculosis infection, with the capacity to drive Th2 immunity.
    Keyser A; Troudt JM; Taylor JL; Izzo AA
    Vaccine; 2011 Nov; 29(50):9308-15. PubMed ID: 22015391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early innate immunity determines outcome of Mycobacterium tuberculosis pulmonary infection in rabbits.
    Subbian S; Bandyopadhyay N; Tsenova L; O'Brien P; Khetani V; Kushner NL; Peixoto B; Soteropoulos P; Bader JS; Karakousis PC; Fallows D; Kaplan G
    Cell Commun Signal; 2013 Aug; 11():60. PubMed ID: 23958185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host and pathogen genetic diversity shape vaccine-mediated protection to
    Cohen SB; Plumlee CR; Engels L; Mai D; Murray TA; Jahn AN; Alexander B; Delahaye JL; Cross LM; Maciag K; Schrader S; Durga K; Gold ES; Aderem A; Gerner MY; Gern BH; Diercks AH; Urdahl KB
    Front Immunol; 2024; 15():1427846. PubMed ID: 39007152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection.
    Gopal R; Monin L; Slight S; Uche U; Blanchard E; Fallert Junecko BA; Ramos-Payan R; Stallings CL; Reinhart TA; Kolls JK; Kaushal D; Nagarajan U; Rangel-Moreno J; Khader SA
    PLoS Pathog; 2014 May; 10(5):e1004099. PubMed ID: 24831696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice.
    Hu Z; Wong KW; Zhao HM; Wen HL; Ji P; Ma H; Wu K; Lu SH; Li F; Li ZM; Shu T; Xu JQ; Lowrie DB; Fan XY
    Mol Ther; 2017 May; 25(5):1222-1233. PubMed ID: 28342639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease.
    Tsenova L; Harbacheuski R; Sung N; Ellison E; Fallows D; Kaplan G
    Vaccine; 2007 Jul; 25(28):5126-32. PubMed ID: 17241704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine efficacy of a
    Kwon KW; Choi HH; Han SJ; Kim JS; Kim WS; Kim H; Kim LH; Kang SM; Park J; Shin SJ
    FASEB J; 2019 May; 33(5):6483-6496. PubMed ID: 30753099
    [No Abstract]   [Full Text] [Related]  

  • 11. Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis.
    Hwang SA; Wilk KM; Budnicka M; Olsen M; Bangale YA; Hunter RL; Kruzel ML; Actor JK
    Vaccine; 2007 Sep; 25(37-38):6730-43. PubMed ID: 17698261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced effect of BCG vaccine against pulmonary Mycobacterium tuberculosis infection in mice with lung Th17 response to mycobacterial heparin-binding hemagglutinin adhesin antigen.
    Fukui M; Shinjo K; Umemura M; Shigeno S; Harakuni T; Arakawa T; Matsuzaki G
    Microbiol Immunol; 2015 Dec; 59(12):735-43. PubMed ID: 26577130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
    Coppola M; Ottenhoff TH
    Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette-Guérin (BCG) against Mycobacterium tuberculosis.
    Maurya SK; Aqdas M; Das DK; Singh S; Nadeem S; Kaur G; Agrewala JN
    BMC Infect Dis; 2020 Sep; 20(1):677. PubMed ID: 32942991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
    Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B
    Front Immunol; 2018; 9():2371. PubMed ID: 30386336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes.
    Graustein AD; Horne DJ; Fong JJ; Schwarz F; Mefford HC; Peterson GJ; Wells RD; Musvosvi M; Shey M; Hanekom WA; Hatherill M; Scriba TJ; Thuong NTT; Mai NTH; Caws M; Bang ND; Dunstan SJ; Thwaites GE; Varki A; Angata T; Hawn TR
    Tuberculosis (Edinb); 2017 May; 104():38-45. PubMed ID: 28454648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological basis of early clearance of Mycobacterium tuberculosis infection: the role of natural killer cells.
    Abebe F
    Clin Exp Immunol; 2021 Apr; 204(1):32-40. PubMed ID: 33315236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.
    Sharpe S; White A; Sarfas C; Sibley L; Gleeson F; McIntyre A; Basaraba R; Clark S; Hall G; Rayner E; Williams A; Marsh PD; Dennis M
    Tuberculosis (Edinb); 2016 Dec; 101():174-190. PubMed ID: 27865390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of pulmonary DC function by vaccine-encoded GM-CSF enhances protective immunity against Mycobacterium tuberculosis infection.
    Nambiar JK; Ryan AA; Kong CU; Britton WJ; Triccas JA
    Eur J Immunol; 2010 Jan; 40(1):153-61. PubMed ID: 19830735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.